Our translational research and accelerated product commercialization strategy is cemented by B2B partnerships and academic-industry collaborations. We are regularly pursuing new developments and joint venture opportunities. Whether we can help expand your research into a market ready solution, integrate our technologies into your ecosystem, or work together on an innovative co-development, we’d like to hear from you.
CT-based Rigidity Analysis (CTRA) is a fracture risk test for patients with bone cancer. BioSensics was awarded a series of grants from the National Institutes of Health to develop this technology, in collaboration with Beth Israel Deaconess Medical Center. Market release for non-medical use is expected by the end of 2018.
A wearable sensor system to promote recovery from hemiparetic stroke by encouraging use of the impaired arm during activities of daily living.
Under development in partnership with Spaulding Rehabilitation Hospital. Clinical trials beginning in 2018.
U.S. Patent No: 9,311,789
In April 2015, GreatCall, a leader in mobile health and safety solutions for active aging, added ActivePERS fall detection technology to its 5Star urgent response service.
In September 2016, GreatCall launched the Lively Wearable, its newest sensor containing ActivePERS technology.